Detalhe da pesquisa
1.
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer.
Br J Cancer
; 113(2): 199-203, 2015 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26125448
2.
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.
Br J Cancer
; 101(10): 1724-30, 2009 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19861964